Savient Pharmaceuticals Inc Com (NASDAQOTH:SVNTQ)

CAPS Rating: 2 out of 5

A biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.

Results 1 - 20 of 65 : 1 2 3 4 Next »

Recs

0
Member Avatar CarlosDK (< 20) Submitted: 11/15/2012 6:11:18 AM : Outperform Start Price: $1.13 SVNTQ Score: -147.43

IHS on finviz

Recs

3
Member Avatar HoldThatWinner (30.88) Submitted: 5/3/2012 10:25:32 AM : Outperform Start Price: $2.18 SVNTQ Score: -142.15

Loaded up in RL yesterday, I'll take a chance on the destruction.

Recs

0
Member Avatar stainsolution (33.03) Submitted: 4/9/2012 7:40:59 PM : Outperform Start Price: $1.93 SVNTQ Score: -145.39

Chart looks to have bottomed out.

Recs

0
Member Avatar RBuskey106 (45.11) Submitted: 3/15/2012 1:45:39 PM : Outperform Start Price: $1.94 SVNTQ Score: -143.14

looks to have bottomed out.

Recs

0
Member Avatar mcad6641 (< 20) Submitted: 3/15/2012 3:06:40 AM : Outperform Start Price: $1.92 SVNTQ Score: -142.65

Krystexxa big in EU

Recs

0
Member Avatar Itchy16 (< 20) Submitted: 3/6/2012 4:45:27 PM : Outperform Start Price: $1.86 SVNTQ Score: -148.50

Oversold at this level

Recs

1
Member Avatar 1Ning (< 20) Submitted: 2/18/2012 1:42:58 PM : Outperform Start Price: $2.11 SVNTQ Score: -146.70

krystexxa launch.

Recs

0
Member Avatar explainstuff (83.31) Submitted: 12/16/2011 10:12:33 PM : Outperform Start Price: $2.38 SVNTQ Score: -164.52

Market Maker Selling phase soon?

Recs

0
Member Avatar kendricklamar (70.00) Submitted: 11/20/2011 12:44:41 PM : Outperform Start Price: $2.35 SVNTQ Score: -166.89

jcode

Recs

1
Member Avatar jbpontes (43.35) Submitted: 8/25/2011 1:55:54 PM : Outperform Start Price: $3.91 SVNTQ Score: -171.56

The market has oversold biotech shares and this company was also affected. I beat it will growth >100%

Recs

0
Member Avatar ExtremesTracker (45.55) Submitted: 8/7/2011 10:46:58 PM : Outperform Start Price: $4.05 SVNTQ Score: -171.62

4 Fallen Bevo picks that are based in US that have very high short interest and are currently above $1/share.

FRZ, SVNT, JRCC, PCBC

Recs

1
Member Avatar jaugolfer68 (< 20) Submitted: 4/6/2011 1:16:12 PM : Outperform Start Price: $10.61 SVNTQ Score: -150.45

New FDA approved drug sales starting this year.

Recs

1
Member Avatar chimpcontest (< 20) Submitted: 2/21/2011 1:44:42 PM : Outperform Start Price: $9.91 SVNTQ Score: -150.75

Euro247 haiku

Did not sell oh well

Plenty money of their own

Drug demand will grow!

Recs

0
Member Avatar russiangambit (29.30) Submitted: 2/6/2011 4:17:47 PM : Outperform Start Price: $9.63 SVNTQ Score: -152.67

short squeeze ahoy

Recs

0
Member Avatar sdbeck23 (79.56) Submitted: 2/3/2011 8:21:03 PM : Outperform Start Price: $9.83 SVNTQ Score: -153.39

why not

Recs

1
Member Avatar EclecticRecluse (79.66) Submitted: 11/22/2010 7:31:11 AM : Underperform Start Price: $12.17 SVNTQ Score: +167.67

Extremely High Price for Book Value

Recs

0
Member Avatar Brisking (< 20) Submitted: 11/18/2010 1:13:45 PM : Outperform Start Price: $12.10 SVNTQ Score: -166.82

When Savient get their sales team together and prove that the gout drug is a winner, they should become a play once again for the major pharmas.

Recs

0
Member Avatar dmdurback10 (< 20) Submitted: 10/25/2010 5:57:02 PM : Outperform Start Price: $12.29 SVNTQ Score: -169.93

The stock completely overacted

Recs

2
Member Avatar randomtask16 (92.96) Submitted: 10/25/2010 11:39:13 AM : Underperform Start Price: $20.05 SVNTQ Score: +168.39

Limited pipeline, Niche Drugs and stingy FDA are keeping me away from this one for now.

Recs

0
Member Avatar dchersey1 (< 20) Submitted: 9/17/2010 3:58:56 PM : Outperform Start Price: $20.59 SVNTQ Score: -178.41

savients capitalization will increase greatly. The Ktyess drug will be used by phys. immensely. Their could be a twist in its use| dchersey1

Results 1 - 20 of 65 : 1 2 3 4 Next »

Featured Broker Partners


Advertisement